PharmaCyte Biotech, Inc.
Company Information
Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation NV
Business Address 3960 HOWARD HUGHES PARKWAY, LAS VEGAS, NV, 89169
Mailing Address 3960 HOWARD HUGHES PARKWAY, LAS VEGAS, NV, 89169
Phone (917) 595.2850
Fiscal Year End 0430
EIN 621772151
Financial Overview
FY2025
$59.90M
Total Assets
$20.39M
Total Liabilities
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 4 Insider stock transaction report | January 7, 2026 | View on SEC |
| 10-Q Quarterly financial report | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 8-K Current report of material events | December 5, 2025 | View on SEC |
Material Events
8-K Financial Distress December 5, 2025
High Impact
- PharmaCyte Biotech received an official notice from Nasdaq for failing to meet the minimum $1.00 bid price rule.
- The company's common stock closed below $1.00 per share for 30 consecutive business days, risking potential delisting from Nasdaq.
Insider Trading
BUY 2 insiders
6 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2836)
AMGEN INC
AMGN Biological Products, (No Diagnostic Substances)
Vitro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
INTENSITY THERAPEUTICS, INC.
INTS Biological Products, (No Diagnostic Substances)
PALISADE BIO, INC.
PALI Biological Products, (No Diagnostic Substances)
Surrozen, Inc./DE
SRZN Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.